DT
Dynavax Technologies Corporation
🇺🇸XNAS.DVAXUnited StatesHealthcare
$15.50USDunchanged 0.00 (0%)OpenDelayed5:09 PM
Price$15.500.00 (0%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US2681582019
- CUSIP
- 268158102
Company
- Employees
- 405
- Headquarters
- EmeryVille, United States
- Website
- https://www.dynavax.com
- CEO
- Mr. Ryan Spencer
Market
- Shares outstanding
- 113.7M
- Market cap
- $1.76B
Highlights
- Market cap
- $1.76B
- EPS LTM
- -$0.38calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -40.60calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $330.51M+26.73%up year on year
- Net income
- -$43.4M-311.94%down year on year
- Gross margin
- 83.17%+0.39%up year on year
- Free cash flow
- $80.54M+255.26%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.